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Background: Global reports have high-
lighted the increasing prevalence of
Candida tropicalis infections as well as
organism’s drug resistance. This study
aimed at identifying azole resistance mark-
ers in clinical isolates of C. tropicalis,
which will be a great resource for devel-
oping new drugs. Methods: Two suscep-
tible and resistant isolates of C. tropicalis
were recovered from an epidemiological
investigation of candidiasis in immunocom-
promised patients. C. tropicalis ATCC 750
was used as reference strain. Antifungal
susceptibility to fluconazole and itracona-
zole was determined using Clinical and Lab-
oratory Standards Institute (CLSI) method.
Complementary DNA-amplified fragment
length polymorphism (cDNA-AFLP) tech-
nology and real-time reverse-transcriptase
(RT) PCR were used for identification
of potential genes involved in azole re-
sistance of C. tropicalis clinical isolates.
Results: Five genes encoding the follow-
ing enzymes were identified as superoxide
dismutase (SOD) implicated in antioxidant
defense, ornithine aminotransferase
(OAT), acetyl ornithine aminotransferase
(ACOAT), adenosylmethionine-8-amino-
7-oxononanoate aminotransferase (DAPA
AT), and 4-aminobutyrate aminotransferase
(ABAT)—belonging to pyridoxal phosphate
(PLP) dependent enzymes and acting in an
important physiological role in many fungal-
cell cycles. Real-time RT-PCR confirmed
mRNA level of the aforementioned genes.
Conclusion: Our findings showed that fac-
tors such as PLP-dependent enzymes and
SOD might be implicated in drug resistance
in C. tropicalis clinical isolate. Therefore,
further studies are required to explore the
accurate biological functions of the men-
tioned genes that would be helpful for effec-
tive drug development. J. Clin. Lab. Anal.
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INTRODUCTION
Candida species are the most common cause of oppor-
tunistic fungal infections (1). Infections due to oppor-
tunistic fungal pathogens have increased mainly over the
past twodecades, related to increasing patient populations
such as persons with AIDS, individuals undergoing solid
organ and bone marrow transplantation, and immuno-
suppressed and cancer patients (2, 3). Candida albicans is
the most significant agent of candidiasis in immunocom-
promised patients (4, 5).
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C. tropicalishas long been proposed to be an agent of in-
vasive fungal infections in patients with cancer, leukemia
and in hematopoietic stem cell transplantation recipients
(6, 7). It has been well determined that among non-
albicans Candida species C. tropicalis is the third lead-
ing cause of Candida infections as well as the second in
respiratory specimens (3, 4).
There are currently three main classes of antifungal
agents for treatment of candidiasis: the polyenes, azoles,
and echinocandins (8). Fluconazole is the most highly
used azole drug (9). Drug resistance is an important issue
for treating infections caused byCandida spp. (7). Clinical
isolates of C. tropicalis resistant to azoles, particularly to
fluconazole, are increasingly reported (3,5,10). According
to the literature, fluconazole resistance rate is dramati-
cally increasing among clinical isolates of C. tropicalis, a
third leading etiologic agent in candidiasis (11, 12).
The cellular and molecular foundations of resistance
are strongly dependent on the method of antifungal ac-
tivity.Molecular resistancemay contain detection of point
mutation, gene conversions, and gene amplifications caus-
ing overexpression or mitotic recombination (10, 13). Al-
though the molecular mechanisms of drug resistance in
the C. tropicalis are not completely established, azole re-
sistance mechanisms have been studied basically in C.
albicans andC. glabrata (14,15). Lanostrol 14-α demethy-
lase is encoded by the ERG11 gene. Involvement of
overexpression and point mutation in ERG11 have been
reported in azole resistance (16,17). The effluxpumps such
as ATP-blinding cassette (ABC) transporters and major
facilitator super family (MFS) proteins includingCandida
drug resistance (CDR) 1 and multidrug resistance (MDR)
1 genes have been related to azole resistance in several
Candida species, especially C. albicans strains (18).
Complementary DNA-amplified fragment length poly-
morphism (cDNA-AFLP) method is one of the appropri-
ate transcriptomic methods for gene discovery that does
not require prior sequence knowledge of the genes (19).
This method is used for the identification of new genes
in various organisms such as Candida yeast (19, 20). In
this study, cDNA -AFLP method was utilized for iden-
tification of molecular resistance markers in C. tropicalis
isolates from immunocompromised patients.
MATERIALS AND METHODS
Yeast Isolates
Two clinical isolates of C. tropicalis composed of iso-
lates sensitive and resistant to fluconazole and itra-
conazole were used in this study. These isolates were
previously recovered from oropharyngeal samples of im-
munocompromised patients and stored in culture collec-
tion of Department of Medical Mycology and Parasitol-
ogy of Tehran University of Medical Sciences.
C. tropicalisATCC 750 was used as a reference. All clin-
ical isolates were identified by standard mycological and
biochemical methods including colony color in CHROM
agar Candida (CHROMagar, Paris, France) and API20C
AUX system (Bio Merieux, Lyon, France).
Culture Conditions and Drug Susceptibility
Testing
Three strains of C. tropicalis including two clinical iso-
lates and a reference strain were cultured on a yeast ex-
tract peptone dextrose (YEPD) agar plate containing 5 g/l
yeast extract (Baltimore Biological Laboratory, Washing-
ton, USA), 10 g/l peptone (Merck, Frankfurt, Germany),
20 g/l dextrose (Merck, Frankfurt, Germany), and 20 g/l
agar (Biolife, Milan, Italy), and then the plates were incu-
bated for 72 h at 37°C. Later a single colony of each isolate
and reference strain was transferred in YEPD broth and
incubated for 24 h at 37°C.
The in vitro susceptibility of two clinical isolates to flu-
conazole and itraconazole was determined by broth mi-
crodilution method according to CLSI M27-A3 standard
(21). C. krusei ATCC 6258 was used for quality control.
After 48 h of incubation at 35°C, minimum inhibitory
concentrations (MICs) were determined visually with the
aid of mirror by comparison of growth in the wells con-
taining the drug with the drug-free controls. TheMICs of
azoles were determined as lowest concentration support-
ing 50% growth inhibition compared to the growth in
control wells. All tests were performed at least two times.
The MICs of fluconazole and itraconazole for resistant
isolate were 64 and 16 μg/ml, respectively.
RNA Extraction and cDNA Synthesis
Total RNA was extracted from the log phase using
the RNeasy protect mini kit (Qiagen, Hilden, Germany),
following the mechanical infraction of the yeast cells by
sonication with acid-washed glass beads (0.45–0.52 mm
diameter). To avoid any genomic contamination, all RNA
samples were treated with RNase-free DNase (Qiagen,
Hilden, Germany) as explained by the manufacturer.
The quantity and quality of RNA were determined
using nanodrop (ND-1000, Thermo Fisher Scientific,
Waltham, Massachusetts, USA) and the electrophoresis
on 1.5% agarose gel.
The single-strand cDNA (sscDNA) for each of the clin-
ical isolates and the reference strain was synthesized using
6 μg RNA, 20 pmol/μl random hexamer (Fermentas,
Burlington, Canada), 20 pmol/μl oligo-dT (Fermentas,
Burlington, Canada), and 10 mM of dNTP mix (Fer-
mentas, Burlington, Canada) incubated at 65°C for 10
min and then cooled on ice followed by addition of 20 U
Ribolock (Fermentas, Burlington, Canada), 7.5 μl of 5×
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TABLE 1. Adaptors Used in cDNA-AFLP Method
Adaptors Sequence (5′–3′)
ADEcoR I ACCGACGTCGACTATCCATGAAG
adEcoR I AATTCTTCATGG
Pre amp ACCGACGTCGACTATCCATGAAGAATTC
S1Ecor I ACCGACGTCGACTATCCATGAAGAATTCC
S2Ecor I ACCGACGTCGACTATCCATGAAGAATTCG
S3Ecor I ACCGACGTCGACTATCCATGAAGAATTCA
S4Ecor I ACCGACGTCGACTATCCATGAAGAATTCT
reverse-transcriptase (RT) buffer (Fermentas, Burlington,
Canada) and 200 U of Moloney Murine Leukemia virus
(M -MuLV)RT enzyme (Fermentas, Burlington, Canada)
and then incubated at 72°C for 10 min followed by incu-
bation at 42°C for 60 min. The accuracy of cDNA was
checked with actin (ACT) gene primers as housekeeping
(Table 2). The PCR condition was initial denaturation
step for 5 min at 94°C, 30 cycles of denaturation for 30
sec at 94°C, annealing for 30 sec at 62°C, an extension
for 7 min at 72°C with a final extension of 72°C.
Double-strand cDNA (dscDNA)was synthesized using
40UDNA polymerase I (Fermentas, Burlington,Canada)
and 10 mM dNTP mix at 16°C for 3 h and was pre-
cipitated with ethanol. The quantity and quality of syn-
thesized dscDNAwere determined using nanodrop (ND-
1000, ThermoFisher Scientific,Waltham,Massachusetts,
USA) and the electrophoresis on 2% agarose gel.
cDNA-AFLP
cDNA-AFLP method was performed as explained
previously with somemodifications (20). Twomicrograms
purified dscDNAwas digested with 5U EcoR1 restriction
enzyme (Fermentas, Burlington, Canada) for 4 h at 37°C,
and the enzyme was inactivated at 80°C for 20 min. The
digested components were ligated to AFLP adaptors
(Table 1), 8 μg ADEcoR1 and 4 μg adEcoR1 in a final
volume of 60 μl reactions. Briefly, it was conducted 1 min
at 50°C, decreasing to 10°C over 1 h (i.e., 1°C/1.5 min)
and then 6 U T4 DNA Ligase (Takara, Tokyo, Japan)
was added and incubated at 16°C for 16 h.
The preamplification was performed with preamp
primers (Table 1) on ligated fragments according to the
following PCR conditions: 5 min of denaturation at 94°C;
30 cycles of 94°C for 30 sec; 63°C, 30 sec; 72°C, 30 sec; and
final extension at 72°C for 5 min. The sensitive amplifica-
tion was performed using sensitive primers with the same
preamplification PCR conditions. These primers included
adaptor sequences in addition of one newnucleotide at the
3
′
end (Table 1). ThePCRproducts resulting from this step
were separated by 8% nondenaturated polyacrylamide gel
electrophoresis (PAGE) and stained with silver nitrate.
Then, the gels were studied for the existence of differen-
tially expressed transcription-derived fragments (TDFs).
Isolation, Cloning, and Sequencing of TDFs
Differentiated TDFs were extracted from the PAGE
and reamplified with appropriate sensitive primers. The
PCRproductswere checkedusing electrophoresis on 1.5%
agarose gel. Then, they were cloned using TOPO TA
cloning kit (Invitrogen, Carlsbad, California, USA) and
screened with universal primers, M13 forward (−20) and
M13 reverse (Table 3), according to the following PCR
condition: 30 cycles of 94°C for 1 min, 55°C for 1 min,
72°C for 1 min, and 72°C for 7 min. The PCR products
were checked by agarose (Merck, Frankfurt, Germany)
gel electrophoresis. The recombinant plasmids containing
unknown DNA were sequenced using M13 forward and
reverse primers. Sequence results were analyzed in nonre-
dundant nucleic and protein databases BLAST (www.
ncbi. nlm. nih. gov/ BLAST/).
Real-Time RT-PCR Analysis
Real-time RT-PCR was carried out to detect the
mRNA expression level of TDF-derived genes between
two resistant and sensitiveC. tropicalis isolates by specific
primers designed by primer3-Bio Tools-University of
Massachusetts Medical (biotools. Umassmed. edu/
bioapps/ primer3-www. cgi, Table 2). The sscDNA for
each of the clinical isolates and the reference strain was
synthesized from 6 μg of total RNA using Quantitect
Reverse Transcription kit (Qiagen, Hilden, Germany)
following the manufacturer’s instructions. RT-PCR
was performed in 25 μl reactions containing 2.5 μl
cDNA target, 300 nM forward and reverse primers, and
1×Real-TimePCRMasterMixE3 containingEvaGreen,
dUTP, and ROX (500 nM) (GeneON, Ludwigshafen,
Germany). Tests were performed in triplicate by StepOne-
Plus Real-Time PCR system (Applied Biosystems, Foster
City, California, USA).
The PCR condition was as follows: denaturation at
95°C for 60 sec and 40 cycles of denaturation at 95°C
for 15 sec, annealing at 55°C for 30 sec, and extension at
72°C for 30 sec. The actin gene was used as a housekeep-
ing gene and expression level of each gene was calculated
by the 2−Ct method as previously described (22). Serial
dilutions of the sscDNA were used for calculation of the
efficiencies of the primer sets on real-time PCR.
Statistical Analysis
All tests were performed at least two times and the
results are explained as the mean ± SDs. The value of dif-
ferences was defined by Student’s t-test and the acceptable
level of significance was 95% (P < 0.05).
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TABLE 2. Primers Used in This Study
Gene GenBank Product
name Primer Nucleotide sequence (5′–3′) accession no. size (bp)
ACT ACT F
ACT R
GAAGATCTTGTCTGAACGTGGTT
GAGGTTTGCATTTCTTGTTCG
AJ389059.1 120
SOD SOD F
SOD R
AGGTGGTGGTCAACATCCAG
AAGCCCAACCAGAACCTTG
XM-002550104 131
OAT OAT F
OAT R
GGTATTGTTGTTCCGCCAGA
TTCACCCCCTTTGAGTGTTC
XM-002545168.1 146
ACOAT ACOAT F
ACOAT R
TCACCTTTAATCCCAGGAG
GGATTAACTCCACCTTCACC
XM-002547867.1 128
ABAT ABAT F
ABAT R
GTTTATCTGGTGCCGATGCT
CCAAATCTGGAGAACCTGGA
XM-002547219.1 147
DAPA AT DAPAAT F
DAPAAT R
ACCGGTGTCTGGAAATCTCA
TTCAATCACTCCCACAGCAC
XM-002546330.1 129
RESULTS
Antifungal susceptibility
Drug sensitivity of C. tropicalis isolates to fluconazole
and itraconazole was determined CLSI guideline (docu-
ment M27-A3). Results showed that MIC values of flu-
conazole were64 and 1μg/ml and for itraconazole were
16 and 0.25 μg/ml in resistant and sensitive isolates, re-
spectively. The MIC values of fluconazole and itracona-
zole for resistant isolate were about 64 times higher than
for the sensitive isolate.
Fig. 1. An illustration representative of cDNA-AFLP on PAGE. Sen-
sitive amplification of cDNA-AFLP on a PAGE from three different
primer combinations: S1S2EcoRI, S1S4EcoRI, S2S4EcoRI. The ar-
rows show differentially expressed TDFs in resistant and sensitive C.
tropicalis isolates. M, (50 bp) molecular weight marker; S, sensitive; R,
resistant.
cDNA-AFLP Analysis of Clinical Isolates
To detect the mRNA expression level related to molec-
ular resistance, a cDNA-AFLP technique was used on
drug-resistant and drug-sensitive C. tropicalis isolates. To
study the validity of cDNA, the actin gene was used as
a housekeeping gene and RT-PCR using specific primers
related to actin (120 bp) was conducted (data not shown).
cDNA-AFLP results determined differential expression
of TDFs on 8% nondenaturating PAGE using silver
staining by 10 differential primer combinations (Fig. 1).
Because of restriction enzyme digestion in this method,
several transcripts may have the similar size. Accordingly,
several bands may be one gene or one band may contain
more than one gene. Fourteen TDFs were extracted from
the cDNA-AFLP on PAGE and reamplified.
Finally, each favorable band was identified by cloning
andDNAsequencing. TheBLASTanalysis indicated that
six sequences had remarkable similarities with genome
database (E-value  10−5). Five target genes containing
superoxide dismutase (SOD), ornithine aminotransferase
(OAT), acetyl ornithine aminotransferase (ACOAT),
adenosylmethionine-8-amino-7-oxononanoate amino-
transferase (DAPA AT), 4-aminobutyrate amino-
transferase (ABAT) and one unknown gene coding
hypothetical proteins were detected with different mRNA
expression levels in resistant C. tropicalis isolate com-
pared to sensitive isolate and sensitive reference strain.
Some characteristics of these genes are presented in
Table 3.
Real-time RT-PCR was used to investigate the differ-
ent mRNA expression of target genes in the resistant and
sensitive C. tropicalis clinical isolates (Fig. 2). Data show
a very considerable upregulation of SOD (32.221-fold),
OAT (88.208-fold), ACOAT (69.277-fold), DAPA AT
(59.933-fold), andABAT (59.933-fold) in resistant clinical
isolate compared to sensitive clinical isolate (P < 0.05).
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TABLE 3. Sequences Identified by cDNA-AFLP
Code no. Annotation Length (bp) Accession no.
1 SOD 234 XP 002550150.1
2 OAT 436 XP 002545232.1
3 ACOAT 448 XP 002547913.1
4 DAPA AT 433 XP 002546376.1
5 ABAT 471 XP 002547265.1
6 Hypothetical
proteins
147 XP 002547165.1
Fig. 2. Relative gene expression pattern of target genes in resistant and
sensitiveCandida tropicalis isolates by real-timeRTPCR. The expression
of actin gene was used to normalize the data. R, resistant; S, sensitive.
Values are mean ± SD. *P < 0.05.
DISCCUSION
Among non-albicans Candida species, C. tropicalis rep-
resents the third most common species but the second
in respiratory specimens (3, 4). Resistance to azoles, es-
pecially to fluconazole, in clinical isolates of C. tropicalis
is increasingly reported (11, 12). Antifungal resistance of
Candida species is a great problem in treating infections
caused by these agents (7).
This study describes the role of five target genes includ-
ing SOD, OAT, ACOAT, DAPA AT, and ABAT on the
azole resistance of C. tropicalis, which were identified us-
ing cDNA-AFLP. Our results demonstrate upregulation
of these five genes in resistant C. tropicalis clinical isolate
for the first time. According to this study, these five genes
seem to be potential new markers in molecular resistance
that confirmed upregulation of expression level of these
genes by real-time RT-PCR.
SOD catalyzes the conversion of superoxide radical to
hydrogen peroxide and dioxygen (23). According to the
metal cofactor, four classes of SOD exist: there are iron
(Fe SOD), manganese (Mn SOD), copper and zinc (CuZn
SOD), and nickel (Ni SOD) types of enzymes (23, 24).
Most antifungal drugs were shown to induce cell death in
yeast with apoptotic mechanism by the generation of high
intracellular reactive oxygen species (ROS) levels (25,26).
ROS is one of themajor causes of damage toDNA, pro-
teins and lipids, and mutations (27, 28). In this study we
report the upregulation of SOD in resistant C. tropicalis
clinical isolate. SODs play a significant role in protect-
ing cells from the superoxide ion toxicity (23,29). Several
studies have described the effects of Cu/Zn SOD on the
morphological phenotype, oxygen metabolism, and viru-
lence of C. albicans (23, 24).
SOD5 gene, which seems to be an important cofac-
tor in the virulence, switches from yeast to hyphal forms
and protects C. albicans cell against intracellularly gen-
erated superoxide radicals (24). SOD5 expression levels
were increased when cells grew in the presence of high
salt concentrations. Martchenko et al. reported there is a
correlation between generation and detoxification of su-
peroxide in respiratory of C. albicans (24).
It has been suggested that different factors such as an-
tioxidant defense systems of C. albicans play critical roles
for resistance against host immune response (23). Hwang
et al. showed that the Cu/Zn SOD deficient strain re-
vealed an increased susceptibility to fungicidal damage by
macrophages and attenuated virulence in a mouse model
for systemic candidiasis. Our results are in accordance
with the above-mentioned studies that indicated upregu-
lation of SOD in resistant C. tropicalis clinical isolate.
OAT, ACOAT, DAPA AT, and ABAT belong to pyri-
doxal phosphate (PLP) dependent aspartate aminotrans-
ferase superfamily. Aspartate aminotransferase is a key
enzyme in the nitrogen metabolism of all organisms
(30, 31). Various studies determined that all proteins
belonging to this family are involved in different bi-
ological processes including transamination (movement
of amino groups), decarboxylation (removing COOH
groups), racemization (redistribution of enantiomers),
and various side-chain reactions depending on the en-
zyme involved (30–32).
These enzymes have been considered to play impor-
tant physiological role of fungal-cell cycle (33,34). ABAT
metabolic machinery is interfaced with some of the ma-
jor facets of fungal-cell cycle. These include nitrogen and
energy metabolism, sporulation, differentiation, and de-
velopment; and the most important facets include nitro-
gen and carbon source, energy metabolism, sporulation,
differentiation, and development (33). It has been under-
stood that some biomolecules including putrescine, sper-
midine, and spermine produced by the OAT and ABAT
enzymes known as compounds implicated in developmen-
tal processes and stress tolerance (33, 35–37). Fungi have
an unusually high requirement of polyamines as essential
components for cell growth (33,35).
It has been reported that overexpression and genetic al-
terations of various genes such asERG11 depend on azole
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resistance (16, 17). The efflux pumps such as ABC trans-
porters and MFS proteins including CDR1 and MDR1
genes have been related to azole resistance in several Can-
dida species, especially in C. albicans strains (18).
The most ubiquitous mechanism resistant to drug tox-
icity is the elimination of drugs out of the cell using ABC
membrane transporters. These molecular pumps actively
translocate drugs through the cell membrane by using
the energy obtained from ATP hydrolysis (38). The OAT,
ACOAT, DAPA AT, and ABAT enzymes play a main role
in the production of tricarboxylic acid cycle (TCA cycle)
precursors. Therefore, overexpression of these genes leads
to the production of high amounts of ATP and energy in
fungal cells, so that a part of the ATPs may be used by
multidrug efflux pumps for translocation of Azole drugs
out of the yeast cells.
We used cDNA-AFLP method for the identification of
target genes involved in azole resistance of C. tropicalis
clinical isolate. We discovered five genes including SOD,
OAT,ACOAT,ABAT, andDAPAAT as well as one hypo-
thetical protein. This is the first report of indication of the
above-mentioned genes in azole resistance of C. tropicalis
clinical isolate. Our findings showed that factors such as
PLP-dependent enzymes and SODmight be implicated in
drug resistance in C. tropicalis clinical isolate. Therefore
further studies are required to explore the accurate bio-
logical functions of the mentioned genes, which would be
helpful for effective drug development.
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